European Primary Care Cardiovascular Society

How EPCCS aims to help primary care physicians across Europe in recognizing and managing CV risk (English)

3' education - Sep. 13, 2019 - EPCCS Council Bucharest, Romania - Prof. Christos Lionis

How EPCCS aims to help primary care physicians across Europe in recognizing and managing CV risk (Greek)

3' education - Sep. 13, 2019 - EPCCS Council Bucharest, Romania - Prof. Christos Lionis

Outreach of EPCCS into European countries: what's in store

3' education - Sep. 13, 2019

Surprising results observed with head-to-head comparison of P2Y12-inhibitors in ACS

3' education - Sep. 16, 2019 - Paris, France - Prof. Stefanie Schüpke

Reduced blood pressure and incidence of hypertension with community-wide salt restriction

3' education - Sep. 16, 2019 - Paris, France - Prof. Jaime Miranda

Reduced CV risk with an intervention targeting identified barriers to care

3' education - Sep. 16, 2019 - Paris, France - Prof. J-D Schwalm

Impact of preventive measures stressed by large community-based studies

3' education - Sep. 16, 2019 - Paris, France - Prof. Salim Yusuf

SGLT2 inhibitor greatly reduced CV risk in HFrEF with or without diabetes

3' education - Sep. 16, 2019 - Paris, France - Prof. John McMurray

Lower LDL-c targets in the 2019 ESC/EAS Dyslipidaemia Guidelines: this is why

5' education - Sep. 9, 2019 - Prof. François Mach

Moving from ignorance on the complexity of HDL to novel therapeutic opportunities

3' education - June 3, 2019 - EAS Maastricht, 2019 - John Chapman, PhD

Efforts to move universal cholesterol screening before the age of 20 forward

3' education - May 29, 2019 - Maastricht, The Netherlands - Professor Kausik Ray, MD

U-Prevent helps to assess individual CV risk and treatment effect

10' education - July 3, 2019 - Jannick Dorresteijn, MD, PhD

The cardiovascular challenge for primary care in diabetes

10' education - Apr. 11, 2019 - EuroPrevent 2019 - Prof. Richard Hobbs, MD

T2DM & CV outcomes: More than glucose management? - Lessons from GLP-1RA trials

10' education - Apr. 11, 2019 - EuroPrevent 2019 - Stephan Jacob, MD

Targeting CVD in diabetes: Novel strategies to tackle the risk

10' education - Apr. 11, 2019 - EuroPrevent 2019 - John Deanfield, MD

Lowering remnants becomes more important, also in light of the obesity epidemic

3' education - June 19, 2019 - EAS 2019 - Prof. Børge Nordestgaard
EPCCS Annual CV Summit

New diagnostic algorithm and therapeutic options in HF management

5' education - Mar. 22, 2019 - Lisbon, Portugal - Peter van der Meer & Monika Hollander
EPCCS Annual CV Summit

Update on managing CV risk in diabetes: what's the evidence?

5' education - Mar. 22, 2019 - Lisbon, Portugal - Kamlesh Khunti & Richard Hobbs
EPCCS Annual CV Summit

Stroke prevention in atrial fibrillation

5' education - Mar. 21, 2019 - Lisbon, Portugal - Michaela Machácová & Richard Hobbs
EPCCS Annual CV Summit

Recent updates to the international Hypertension Guidelines - where do they vary and what should we agree in primary care?

5' education - Mar. 21, 2019 - Lisbon, Portugal - Richard McManus & Richard Hobbs

To improve CV risk profile, not only weight loss is important, but also staying at a lower weight

Literature - Oct. 14, 2019 - Berger SE et al., - J Am Heart Assoc. 2019

In data of the Look AHEAD trial, the effects on CV risk factors of maintaining weight loss were compared with those of weight regain, in year 1 to 4 after a 1-year intensive lifestyle intervention.

Higher AF risk in offspring if they were exposed to smoking parents

Literature - Oct. 10, 2019 - Groh CA et al., - J Am Coll Cardiol 2019

Data of the Framingham Original and Offspring Cohorts show that parental smoking during childhood is associated with a higher AF risk, partly because offspring show higher propensity of smoking.

Association between optimism and reduced risk of CV events and all-cause mortality

Literature - Oct. 10, 2019 - Rozanski A, et al. - JAMA Network Open

A meta-analysis of 15 studies with more than 220,000 individuals showed that a mindset of optimism was associated with reduced risk of CV events and all-cause mortality.

Smartwatch users can soon participate in new large heart health study

News - Oct. 9, 2019

Apple will conduct three health studies, among which the Heart and Movement Study, in partnership with AHA and Brigham and Women’s Hospital, by using the new Research app.

Novel plans and ambitions to enhance EPCCS’ activities formulated during Council Meeting

News - Oct. 9, 2019

EPCCS Council members convened in Bucharest, Romania, to evaluate EPCCS’s current activities and move them forward to increasingly support GP’s across Europe in their daily clinical practice.

How EPCCS aims to help primary care physicians across Europe in recognizing and managing CV risk (English)

EPCCS Council Meeting

3' education - Sep. 13, 2019 - EPCCS Council Bucharest, Romania - Prof. Christos Lionis
A brief impression of how EPCCS activities and plans can be useful for primary care physicians in Greece.

Prof. Christos Lionis gives a brief impression of how EPCCS activities and plans can be useful for primary care physicians.

Outreach of EPCCS into European countries: what's in store

EPCCS Council Meeting

3' education - Sep. 13, 2019
Drs. Cormac O'Dubhghaill (Ireland) and Zehra Daghli (Turkey), two country representatives in the EPCCS Council, summarise the proposed ambitions and plans to increase the outreach of EPCCS to European primary care doctors.

Drs. Cormac O'Dubhghaill (Ireland) and Zehra Daghli (Turkey), two country representatives in the EPCCS Council, summarise the proposed ambitions and plans to increase the outreach of EPCCS to European primary care doctors.

AF risk higher in those with long-term obesity and BMI variability

Literature - Sep. 24, 2019 - Feng T et al., - Eur Heart J. 2019

Large community-based study with repeated weight and height measurements shows that long-term obesity and change in BMI over time are more informative to assess AF risk than current weight.

Lower ACE level due to genetics or pharmacological inhibition associated with lower T2DM risk

News - Sep. 19, 2019

EASD 2019 Study shows that both natural variation in ACE concentrations and lowering blood pressure with ACE inhibitors are associated with lower risk of type 2 diabetes.

Early combination therapy gives better glucose control in newly diagnosed T2DM

News - Sep. 18, 2019

EASD 2019 The VERIFY trial demonstrated that early combination therapy using vildagliptin and metformin was superior to a sequential approach involving later intensification in new T2DM

In normal BMI post-menopausal women, trunk fat was associated with higher and leg fat with lower CVD risk

Literature - Sep. 16, 2019 - Chen G-C et al., - Eur Heart J. 2019

Data of US postmenopausal women with normal BMI show that trunk fat and higher leg fat have opposing associations with CVD risk, while total body fat was not significantly related to CVD risk.

Surprising results observed with head-to-head comparison of P2Y12-inhibitors in ACS

3' education - Sep. 16, 2019 - Paris, France - Prof. Stefanie Schüpke
Contrary to the hypothesis that ticagrelor would be superior, a prasugrel-based strategy reduces ischemic endpoints, without an increased bleeding risk.

ESC 2019 Contrary to the hypothesis that ticagrelor would be superior, a prasugrel-based strategy reduced ischemic endpoints as compared with ticagrelor, without an increased bleeding risk.